Myelofibrosis predicts deep molecular response 4.5 in chronic myeloid leukaemia patients initially treated with imatinib: An extensive, multicenter and retrospective study to develop a prognostic model.
作者信息
Zeng Tian, Yang Xiudi, Wang Yi, Wu Dijiong, Feng Weiying, Lu Ying, Zhu Xiaoqiong, Liu Lirong, Zhou Mei, Zhang Li, Shao Yanping, Qian Honglan, Zhu Feng, Chen Yu, Cao Dan, Huang Li, Feng Xiaoning, Chen Lili, Zhang Gang, Le Jing, Zhu Weiguo, Xia Yongming, Han Yanxia, Jia Yongqing, Tian Guoyan, Zhou Hui, Xu Linjuan, Yin Xiufeng, Tang Qinli, Zhang Yuefeng, Yao Guoli, Lang Xianghua, Zhang Kaifeng, Zhou Xiujie, Guo Junbin, Tu Jinming, Zhao Jianzhi, Wu Gongqiang, Zhang Huiqi, Wu Xiao, Luo Qiulian, Cao Lihong, Chu Binbin, Jiang Wei, Wu Haiying, Huang Liansheng, Hu Meiwei, He Muqing, Zhu Jingjing, Tong Hongyan, Jin Jie, Huang Jian
机构信息
Department of Hematology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Zhejiang Clinical Medical Research Center of Hematology, Hangzhou, China.
出版信息
Clin Transl Med. 2024 Nov;14(11):e70101. doi: 10.1002/ctm2.70101.
Zotero 插件